In this study, we investigated the use of empirical mode decomposition (EMD)-based features extracted from electrocardiogram (ECG) RR interval signals to differentiate between different levels of cardiovascular autonomic neuropathy (CAN) in patients with type 2 diabetes mellitus (T2DM). This study involved 60 participants divided into three groups: no CAN, subclinical CAN, and established CAN. Six EMD features (area of analytic signal representation—; area of the ellipse evaluated from the second-order difference plot—; central tendency measure of SODP—; power spectral density (PSD) peak amplitude—; PSD band power—; and PSD mean frequency—) were extracted from the RR interval signals and compared between groups. The results revealed significant differences between the noCAN and estCAN individuals for all EMD features and their components, except for the . However, only some EMD components of each feature showed significant differences between individuals with noCAN or estCAN and those with subCAN. This study found a pattern of decreasing and values, an increasing value, and a reduction in and values as the CAN progressed. These findings suggest that the EMD outcome measures could contribute to characterizing changes associated with CAN manifestation in individuals with T2DM.
5 January 2022 in Biomedical Physics & Engineering Express
Diabetic peripheral neuropathy (DPN) is associated with loss of motor units (MUs), which can cause changes in the activation pattern of muscle fibres. This study investigated the pattern of muscle activation using high-density surface electromyography (HD-sEMG) signals from subjects with type 2 diabetes mellitus (T2DM) and DPN. Thirty-five adults participated in the study: 12 healthy subjects (HV), 12 patients with T2DM without DPN (No-DPN) and 11 patients with T2DM with DPN (DPN). HD-sEMG signals were recorded in the tibialis anterior muscle during an isometric contraction of ankle dorsiflexion at 50% of the maximum voluntary isometric contraction (MVIC) during 30-s. The calculated HD-sEMG signals parameters were the normalised root mean square (RMS), normalised median frequency (MDF), coefficient of variation (CoV) and modified entropy (ME). The RMS increased significantly ( p = 0.001) with time only for the DPN group, while the MDF decreased significantly ( p < 0.01) with time for the three groups. Moreover, the ME was significantly lower ( p = 0.005), and CoV was significantly higher ( p = 0.003) for the DPN group than the HV group. Using HD-sEMG, we have demonstrated a reduction in the number of MU recruited by individuals with DPN. This study provides proof of concept for the clinical utility of this technique for identifying neuromuscular impairment caused by DPN.
Despite nerve conduction study (NCS) being an established procedure in the evaluation of neuromuscular disorders, its utility has been restrained by commercially available products or approaches presented in the literature that are either costly, physically large, dependent on specialised medical personnel to operate or targeted to specific conditions, evaluating only one or two nerves. Therefore, the objective of this work was to develop a point‐of‐care device for NCS that can be used to evaluate several nerves, yet is still portable, low‐cost and easy to operate. The developed device is composed of three modules: (i) controller module and graphical user interface, responsible for system synchronisation and configuration, data management, graphical visualisation of the evoked action potential and stimulus voltage feedback (maximum error of 3.92%); (ii) stimulation module, which operates in a constant voltage mode and delivers a monophasic stimulus pulse with amplitudes between 0.84 and 230 V, with a discrete increment of 2.32 ± 0.64 V (mean ± SD) and duration of 100 or 200 µs; and (iii) data acquisition module, based on the ADS1298 front‐end that records the evoked action potentials after the stimulus, with a sample rate of 16 or 32 kHz, 24‐bit resolution and selectable voltage gain of 1 up to 12. Results demonstrated that the system could reliably deliver stimulation pulses through different loads (100 Ω, 1 kΩ and 10 kΩ) and accurately record data through frequencies of 10 Hz up to 10 kHz. Additionally, NCS of the ulnar motor nerve in a sample of healthy individuals showed that the device could effectively activate a peripheral nerve and record compound action potentials within normal limits established by the literature.